Monday, August 5, 2013

Bangladesh Pharma Market: 2013



According to the Bangladesh Pharmaceutical Index 2013(1st Quarter) Total Market size of Bangladesh Pharma Market is Tk 9441 Crore (Local only, except import and export). As usual Sqaure Pharmaceutical Limited leading in front with the 18 % of share of total pharma market, though they are slightly behind from the National Market Growth of 8%. Novo Nordisk has the highest 27% growth in this market with only 8 Generics (Insulin based), UniMed UniHealth has the second highest (20%) and Healthcare Pharma (19%) has the third highest growth in the 1st Quarter’2013.



Wednesday, May 9, 2012

Top 20 Brand of Bangladesh Pharma Market: 2011


SI
Brand
Company
Value
(Cr)
GRW
Cont% On Total Sale
1
 SECLO
Square
134
37
1.67
2
 LOSECTIL
SK+F
93
33
1.15
3
 PANTONIX
Incepta
72
37
0.90
4
 NAPA
Beximco
69
30
0.86
5
 NEOTACK
Square
68
25
0.84
6
 CEF-3
Square
65
33
0.80
7
 NEOCEPTIN R
Beximco
64
-2.4
0.80
8
 MAXPRO
Renata
56
66
0.70
9
 ZIMAX
Square
54
23
0.67
10
 CIPROCIN
Square
53
13
0.66
11
 NAPA EXTRA
Beximco
44
44
0.55
12
 XELDRIN
ACI
43
18
0.53
13
 VOLTALIN
Novartis
40
46
0.50
14
 SERGEL
Healtcare
40
56
0.49
15
 FUROCEF
Renata
34
35
0.42
16
 LEBAC
Square
33
0.7
0.41
17
 CEFTRON
Square
32
-4.1
0.40
18
 MIXTARD 30
Novo Nor.
32
36
0.39
19
 ROLAC
Renata
31
27
0.39
20
 OMEP
Aristo
31
43
0.38